Showing 601-610 of 2366 results for "".
Functional Tic Disorder: a Pandemic in a Pandemic
https://practicalneurology.com/diseases-diagnoses/movement-disorders/functional-tic-disorder-a-pandemic-in-a-pandemic/31886/During the COVID-19 pandemic, functional tics have arisen as a neurologic complication of social media.Lipid Management & Smoking Cessation
https://practicalneurology.com/diseases-diagnoses/stroke/lipid-management-smoking-cessation/31863/High cholesterol and smoking are modifiable factors to prevent secondary stroke.The Bidirectional Relationship Between Sleep Disorders and Stroke
https://practicalneurology.com/diseases-diagnoses/sleep/the-bidirectional-relationship-between-sleep-disorders-and-stroke/32191/Sleep disorders and stroke share comorbid and interrelated risk factors that may influence functional outcomes and stroke recovery.Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.Molecular Imaging Biomarkers in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/molecular-imaging-biomarkers-in-dementia/31729/Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.The Immune Stroke Spectrum: Navigating Inflammatory Cerebrovascular Disorders
https://practicalneurology.com/diseases-diagnoses/stroke/the-immune-stroke-spectrum-navigating-inflammatory-cerebrovascular-disorders/49163/This review provides a concise overview of commonly encountered inflammatory cerebrovascular disorders, highlighting their clinical features, diagnostic challenges, and treatment strategies, and emphasizing that despite their complexity, early recognition and systematic management often lead to fFriedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.